Cecile de la Cruz

Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer

Lingyan Jin, Jesse Garcia, Emily Chan et al. · Cancer Research · 2017 · 149 citations · Full text

Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State

Anneleen Daemen, Bonnie Liu, Kyung Song et al. · Cell Metabolism · 2018 · 92 citations · Full text

Pan-cancer Metabolic Signature, Biochemistry, Oncogenic Agent +10

Abstract PD4-14: GDC-0077 is a selective PI3Kalpha inhibitor that demonstrates robust efficacy in <i>PIK3CA</i> mutant breast cancer models as a single agent and in combination with standard of care therapies

Rebecca Hong, Kyle A. Edgar, Kai Song et al. · Cancer Research · 2018 · 25 citations · Full text

Care Therapies, Cancer Biology, Tumor Biology +20

Residual Tumor Cells That Drive Disease Relapse after Chemotherapy Do Not Have Enhanced Tumor Initiating Capacity

Ganapati V. Hegde, Cecile de la Cruz, Jeffrey Eastham‐Anderson et al. · PLoS ONE · 2012 · 19 citations · Full text

Tumor Recurrence, Pathology, Chemotherapy Do +23

Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response

Josefa Chuh, MaryAnn Go, Yvonne Chen et al. · mAbs · 2020 · 18 citations · Full text